摘要
Objective To evaluate the efficacy and safety of different bridging anticoagulant therapies in patients undergoing mechanical heart valve replacement (MHVR) surgery.Methods Consecutive patients undergoing MHVR surgery from January 2018 to December 2018 in First Hospital of Lanzhou University were prospectively enrolled in this study.
作者
LIU Shidong
刘世栋(1st Clin Med Coll,Lanzhou Univ,Lanzhou 730000)